Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
British Journal of Cancer|February 24, 2006
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control studyR Zanetti, S Rosso, C Martinez, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
Quebec's Multi-Party Observatory on Zoonoses and Adaptation to Climate ChangeG Germain, A Simon, J Arsenault, et al.
Bulletin Du Cancer|March 29, 2006
[Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment]Rollon Poinsot, A Altmeyer, T Conroy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA groupE Tchernonog, P Faurie, P Coppo, et al.
Annals of Hematology|September 2, 2016
Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic studyC Orvain, D Luque Paz, I Dobo, et al.
Leukemia|March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75J Reiffers, F Huguet, A M Stoppa, et al.
Nature Medicine|April 15, 1999
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vectorJ P Greelish, L T Su, E B Lankford, et al.
Revue Des Maladies Respiratoires|May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]V Westeel, M P Lebitasy, M Mercier, et al.
ESMO Open|May 27, 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO studyE Alouani, M Mercier, C Flecchia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireA Le Bourgeois, M Labopin, D Blaise, et al.
Pageof 34